1. Resistance to thyroid hormone is modulated in vivo by the nuclear receptor corepressor (NCOR1)Mutations in the ligand-binding domain of TRbeta lead to resistance to thyroid hormone (RTH). These TRbeta mutants function in a dominant negative fashion to interfere with the transcription activity of wild-type TRs, leading to dys-regulation of the pituitary-thyroid axis and resistance in peripheral tissues. The molecular mechanism by which TRbeta mutants cause RTH has been postulated to be an inability of the mutants to properly release the nuclear corepressors (NCORs), thereby inhibiting thyroid hormone TRbetaPV mice that is a model of RTH, expressing a human TRbeta mutant (PV), with mice expressing a mutant Ncor1 allele (Ncor1deltaID mice) that cannot recruit TR or PV mutant. Remarkably, in the presence of NCOR1deltaID, the abnormally elevated TSH and TH levels found in TRbetaPV mice were modestly but significantly corrected. Furthermore, thyroid hyperplasia, weight loss, and other hallmarks of RTH, were also partially reverted in mice expressing NCOR1deltaID. Taken together, these data suggest that the aberrant recruitment of NCOR1 by RTH TRbeta mutants leads to clinical RTH in humans. The present study suggests that therapies aimed at the TR-NCOR1 interaction or its downstream actions could be tested as potential targets in treating RTH.2. Activation of Wnt/beta-catenin signaling in the skeleton of mice with advanced bone formation due to a dominant-negative mutation in the thyroid hormone receptor beta geneThyroid hormone (T3) acts in chondrocytes and bone-forming osteoblasts to control bone development and maintenance but the signaling pathways mediating these effects are poorly understood. TRbetaPV/PV mice have a severely impaired pituitary-thyroid axis and elevated thyroid hormone levels due to a dominant-negative mutant TRbeta (TRbetaPV) that cannot bind T3 and interferes with the actions of wild-type TR. TRbetaPV/PV mice have accelerated skeletal development due to unknown mechanisms. We performed microarray studies in primary osteoblasts from wild-type mice and TRbetaPV/PV mice. Activation of the canonical Wnt signaling in TRbetaPV/PV mice was confirmed by in situ hybridization analysis of Wnt target gene expression in bone during post-natal growth. By contrast, T3 treatment increased phosphorylation of beta-catenin and inhibited Wnt signaling in osteoblastic cells, indicating T3 inhibits the Wnt pathway by facilitating proteasomal degradation of beta-catenin and preventing its accumulation in the nucleus. Activation of the Wnt pathway in TRbetaPV/PV mice, however, suggests a gain-of-function for TRbetaPV that stabilizes beta-catenin despite the presence of increased thyroid hormone levels. These studies demonstrate novel interactions between T3 and Wnt signaling pathways in the regulation of skeletal development and bone formation.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Investigator-Initiated Intramural Research Projects (ZIA)
Project #
Application #
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
National Cancer Institute Division of Basic Sciences
Zip Code
Han, Cho Rong; Park, Sunmi; Cheng, Sheue-Yann (2017) NCOR1 modulates erythroid disorders caused by mutations of thyroid hormone receptor ?1. Sci Rep 7:18080
Milanesi, Anna; Lee, Jang-Won; Yang, An et al. (2017) Thyroid Hormone Receptor Alpha is Essential to Maintain the Satellite Cell Niche During Skeletal Muscle Injury and Sarcopenia of Aging. Thyroid 27:1316-1322
Flamant, Frédéric; Cheng, Sheue-Yann; Hollenberg, Anthony N et al. (2017) Thyroid hormone signaling pathways. Time for a more precise nomenclature. Endocrinology :
Jang, Jeon Yeob; Choi, Sung Yong; Park, Intae et al. (2017) VEGFR2 but not VEGFR3 governs integrity and remodeling of thyroid angiofollicular unit in normal state and during goitrogenesis. EMBO Mol Med 9:750-769
Hine, Christopher; Kim, Hyo-Jeong; Zhu, Yan et al. (2017) Hypothalamic-Pituitary Axis Regulates Hydrogen Sulfide Production. Cell Metab 25:1320-1333.e5
Park, Sunmi; Han, Cho Rong; Park, Jeong Won et al. (2017) Defective erythropoiesis caused by mutations of the thyroid hormone receptor ? gene. PLoS Genet 13:e1006991
Lee, Junguee; Yi, Shinae; Chang, Joon Young et al. (2017) Regeneration of thyroid follicles from primordial cells in a murine thyroidectomized model. Lab Invest 97:478-489
Zhu, Xuguang; Kim, Dong Wook; Zhao, Li et al. (2016) SAHA-induced loss of tumor suppressor Pten gene promotes thyroid carcinogenesis in a mouse model. Endocr Relat Cancer 23:521-33
Park, Jeong Won; Zhao, Li; Willingham, Mark C et al. (2016) Loss of tyrosine phosphorylation at Y406 abrogates the tumor suppressor functions of the thyroid hormone receptor ?. Mol Carcinog :
Sayre, Naomi L; Sifuentes, Mikaela; Holstein, Deborah et al. (2016) Stimulation of astrocyte fatty acid oxidation by thyroid hormone is protective against ischemic stroke-induced damage. J Cereb Blood Flow Metab :

Showing the most recent 10 out of 49 publications